Login to Your Account

MediGene's Phase III Drug Effective In Genital Warts

By Douglas Merrill

Wednesday, December 15, 2004
MUNICH, Germany - MediGene AG completed its second Phase III trial of Polyphenon E, a treatment for genital warts, getting significant clinical effects compared to placebo, as well as good tolerability. (BioWorld International)

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription